Category: Partners

  • Smile Hair Clinic: The First Hair Transplant Clinic in the World to Receive A-Rated Certificate from TEMOS

    Smile Hair Clinic: The First Hair Transplant Clinic in the World to Receive A-Rated Certificate from TEMOS

    ISTANBUL, TR / ACCESS Newswire / September 24, 2025 / Smile Hair Clinic has officially been awarded an A-Rated Certificate by TEMOS International Healthcare Accreditation, a milestone that places the clinic in rarefied company and marks it as the first hair transplant clinic globally to earn this level of recognition. Smile Hair Clinic’s announcement and TEMOS’s confirmation underline a dual achievement: the clinic’s commitment to clinical quality and the growing international visibility of hair restoration as a discipline with rigorous, auditable standards.

    Why this accreditation matters
    Medical accreditation is more than a plaque on the wall; it’s a structured assessment of systems, safety protocols, patient pathways, and continuous improvement processes. TEMOS evaluates outpatient and ambulatory care programs against international benchmarks for patient safety, clinical governance, information security, and patient experience. An A-Rating from TEMOS indicates a clinic not only meets those benchmarks but has demonstrated excellence across the accreditation framework. TEMOS itself publicized Smile Hair Clinic’s achievement and highlighted that this is a world-first for a specialized hair transplant clinic.

    For prospective patients (particularly those considering medical travel) accreditation from a recognized, independent body reduces uncertainty. It signals that clinical protocols are standardized, that infection control and perioperative pathways follow international best practice, and that outcomes tracking and patient communications are formally embedded in the clinic’s operations.

    What Smile Hair Clinic did to stand out?

    Becoming TEMOS-accredited requires documented systems and transparent processes. In Smile Hair Clinic’s case, the pathway to the A-Rating involved a thorough review of clinical governance, staff qualifications, procedure consent processes, aftercare and follow-up systems, and the clinic’s approach to patient information and confidentiality. TEMOS’s report and the clinic’s own press materials note a strong emphasis on patient-centered care and measurable quality indicators.

    Clinics that reach this level typically demonstrate:

    • Consistent clinical audit cycles,

    • Rigorous training and credentialing for surgical teams,

    • Standardized pre-op screening and post-op follow-up,

    • Evidence of infection prevention measures and sterile workflows,

    • Robust patient feedback mechanisms.

    Dr. Mehmet Erdoğan, one of the co-founders of the clinic states that “This certificate is not just a document; it is proof of our promise to provide patients with the highest quality care at international standards. We are proud to represent Turkey on the global stage.”

    Dr. Gökay Bilgin, other co-founder of the clinic added: “Success is not only about medical excellence, but also about safety, ethical values, and a sustainable approach to quality. This achievement reflects our unwavering commitment to patient safety and continuous improvement.”

    What does “TEMOS A-Rating” mean when you are searching for a hair transplant clinic?

    • Confirms the clinic operates to international outpatient care standards.

    • Indicates ongoing quality monitoring is in place – not a one-off inspection.

    • Reassures patients that the clinic’s policies (safety, privacy, documentation) were independently verified.

    These assurances practically reduce risk for patients and help the clinic benchmark itself against international peers.

    The impact on medical tourism and patient choice
    Turkey has long been a global hub for hair restoration. The sector’s competitiveness has pushed clinics to refine techniques, reduce costs, and package comprehensive patient journeys (travel, lodging, surgery, aftercare). Accreditation raises the bar: it differentiates providers who invest in systems and safety from those that compete only on price. For international patients, an A-rated TEMOS certificate is an immediate filter when choosing between clinics that may otherwise appear similar online. Yahoo Finance and major press outlets amplified Smile Hair Clinic’s news, signaling that the recognition matters beyond local industry circles.

    Patient experience: What to look for beyond the certificate?
    Accreditation is a strong signal, but patients should also evaluate personal fit and specifics of care. Look for:

    • Transparent before/after documentation and real patient testimonials,

    • Clear preoperative screening that addresses medical history and expectations,

    • Explicit aftercare plans including follow-up visits or telehealth checks,

    • Clear communication about graft numbers, techniques (FUE, DHI, etc.), and realistic timelines for growth.

    Combine the objective reassurance of accreditation with subjective measures – how the clinic communicates, whether you feel heard in consultation, and whether logistical aspects (travel, accommodation, follow-up) are straightforward.

    How might this influence standards across the industry?
    When a specialty clinic becomes the first to achieve a high international rating, it often triggers a ripple effect. Competitors that previously prioritized volume or price will feel pressure to invest in systems and to seek comparable external validation. For international regulators and patient advocacy groups, the event demonstrates that hair transplant clinics can and should be assessed using the same frameworks as other ambulatory specialties. TEMOS’s announcement of Smile Hair Clinic’s accreditation may therefore serve as a benchmark moment for hair transplant providers worldwide.

    Behind the scenes: Clinical governance and continuous improvement
    Sustaining accreditation is about continuous improvement. That means regular clinical audits, morbidity and complication review meetings, staff continuing professional development, and mechanisms for responding to patient feedback. Clinics that treat accreditation as an annual checkbox tend not to retain high standards; the most resilient providers build quality into everyday practice, from patient intake to long-term outcome measurement.

    Smile Hair Clinic’s statements and the TEMOS notice emphasize these ongoing systems – evidence that the clinic’s leadership views accreditation as the start of a quality journey, not the finish line.

    For clinicians and administrators: Lessons to take away
    If you lead a practice in outpatient surgery or hair restoration, the Smile Hair Clinic case offers practical lessons:

    • Treat accreditation as a systems project (process maps, SOPs, data capture)

    • Invest in staff training and documentation – governance is proven by records

    • Prioritize infection control and patient communication equally

    • Build patient feedback loops that feed into service redesign

    These changes not only prepare an organization for inspection but also improve day-to-day care and outcomes.

    Media Contact

    Company name: Smile Hair Clinic
    Contact Person name: Burak Önal
    E-mail: info@smilehairclinic.com
    website: https://www.smilehairclinic.com/en/
    City: Istanbul
    State: Istanbul
    Country: Turkey

    SOURCE: Smile Hair Clinic

    View the original press release on ACCESS Newswire

  • Atosa USA Awarded Equipment Vendor of the Year by International Dairy Queen

    Atosa USA Awarded Equipment Vendor of the Year by International Dairy Queen

    BREA, CALIFORNIA / ACCESS Newswire / September 24, 2025 / Atosa USA, a premier manufacturer of commercial kitchen equipment, announced today that it has been named Equipment Vendor of the Year by International Dairy Queen (IDQ), the parent company of American Dairy Queen Corporation, which is the franchisor of DQ® restaurants.

    The award was presented at DQ Supply Chain Summit 2025 on September 18 by Dan Kropp, chief supply chain and development officer at IDQ.

    “Atosa USA has gone above and beyond to ensure that DQ franchise owners have the highest quality and most innovative kitchen solutions to deliver consistently positive customer experiences,” said Kropp. “On behalf of IDQ, we congratulate Atosa on this recognition and thank them for their dedication to the DQ system.”

    The Equipment Vendor of the Year Award is granted annually to a DQ vendor that supports DQ franchise owners with the highest quality equipment or equipment distribution services while serving as a key resource throughout the year. As a supplier of refrigeration equipment to DQ restaurants in the U.S., Atosa USA has achieved excellence in the equipment industry and provided quality customer support with a consultative approach to DQ franchise owners.

    “At Atosa USA, our reputation is built on exceptional service and top-tier quality, and we’re proud to bring that value to support the DQ system,” said Jennifer Ward, Chief Revenue Officer at Atosa USA. “We are honored to receive this award, and we thank IDQ for their support.”

    Atosa provides commercial refrigeration equipment to DQ restaurants in the U.S. and has been serving IDQ and DQ franchise owners for two years.

    About Atosa USA
    Atosa is a global leader in commercial foodservice equipment, recognized for its commitment to quality, innovation, and exceptional customer service. Offering a diverse product line that includes refrigeration, cooking equipment, ice machines, combi ovens, and advanced kitchen automation, Atosa delivers reliable, efficient, and durable solutions to meet the needs of modern foodservice operators. With a focus on cutting-edge technology and sustainability, Atosa continues to set industry standards, empowering restaurants, hotels and institutions worldwide. Backed by a global network and a dedication to excellence, Atosa remains at the forefront of shaping the future of commercial foodservice. For more information, visit Atosausa.com.

    About International Dairy Queen, Inc.
    International Dairy Queen, Inc., based in Minneapolis, Minnesota, is the parent company of American Dairy Queen Corporation and Dairy Queen Canada, Inc. Through its subsidiaries, IDQ develops, licenses and services a system of more than 7,700 DQ restaurants in more than 20 countries. IDQ is a subsidiary of Berkshire Hathaway, Inc. (Berkshire), which is led by Warren Buffett, the legendary investor and CEO of Berkshire. For more information, visit DairyQueen.com.

    Contact Information
    Jennifer Ward
    Chief Revenue Officer
    jennifer@atosausa.com
    (614) 309 – 8233

    Johnny Liao
    Managing Director
    johnny@atosausa.com
    (909) 595 – 2688

    .

    SOURCE: Atosa USA, Inc.

    Related Images

    Atosa USA Awarded Equipment Vendor of the Year by International Dairy Queen
    Atosa USA Awarded Equipment Vendor of the Year by International Dairy Queen
    Michael Shao, President and CEO of Atosa USA, and Jill Hunt, Director of National Account Sales at Atosa USA, accepting the Vendor of the Year Award.

    View the original press release on ACCESS Newswire

  • NanoQT Announces First Closing of $14 Million Series A Funding to Redefine Quantum Computing

    NanoQT Announces First Closing of $14 Million Series A Funding to Redefine Quantum Computing

    The Company’s Funding Will Accelerate Developing of the World’s First Distributed Quantum Computers Using NanoQT’s Proprietary Nanofiber-Cavity

    PALO ALTO, CALIFORNIA / ACCESS Newswire / September 24, 2025 / Nanofiber Quantum Technologies, Inc. (NanoQT), a quantum computing company pioneering ultra-low-loss nanofiber cavity-QED interconnects for quantum processors, today announced the first closing of its $14 million Series A financing. Phoenix Venture Partners (PVP), an existing investor, led the round with participation from Brevan Howard Macro Venture Fund, a new investor. WASEDA University Ventures, Inc. (WUV), JAFCO Group Co Ltd, Mirai Creation Fund III (SPARX Asset Management Co., Ltd.), and Keio Innovation Initiative, Inc. (KII), each existing investors, also participated.

    The financing follows more than US$20 million in government R&D grants across Japan and the United States that support NanoQT’s roadmap. “An interconnect engineered for QPUs is the missing link in today’s market and will soon be a major bottleneck to achieving scalable fault-tolerant quantum computing,” said Masashi Hirose, Ph.D., CEO and Co-Founder of NanoQT. “Our proprietary nanofiber-cavity interconnect is highly demanded not only for scaling up quantum computing but also for integrating QPUs with quantum communication capabilities.”

    “We are delighted to continue supporting NanoQT’s breakthrough,” said Nobi Kambe, Ph.D., Managing General Partner at Phoenix Venture Partners (PVP). “NanoQT has demonstrated steady R&D progress, and we believe the company will deliver a disruptive impact in the quantum computing and networking field.” “NanoQT is the best positioned in the quantum field to disrupt interconnects.”

    Why It Matters

    The quantum interconnect is an emerging, critical device class-essential not only for modularizing quantum processors but also for extending them into networked and communication-enabled systems. NanoQT’s approach is an ultra-low-loss nanofiber cavity that functions as an end-to-end fiber-optic interconnect, enabling extremely efficient conversion of qubit signals into photonic signals-a capability fundamentally grounded in cavity quantum electrodynamics (QED).

    NanoQT’s initial product is highly engineered for neutral-atom QPUs, which today represent one of the most scalable quantum computing architectures. Yet these systems will face per-unit scalability limits within a few years. NanoQT’s interconnect provides a path beyond those limits, while also positioning the company to address the emerging quantum repeater market, which is essential for building long-distance quantum networks.

    Use of Proceeds and Next Milestones

    • Demonstration of a distributed quantum computing system using NanoQT’s interconnect and standard fiber links

    • Productization of the nanofiber cavity-QED interconnect for neutral-atom QPUs

    • Expansion of engineering and manufacturing capacity in College Park, Maryland, and Tokyo

    About NanoQT

    NanoQT is a quantum-hardware company building ultra-low-loss nanofiber cavity-QED interconnects that physically integrate with quantum processors to enable modular and networked quantum computing as well as compatibility with quantum communication. Headquartered in Palo Alto, California, with operations in College Park, Maryland and Tokyo, Japan, NanoQT combines Japan-born engineering excellence with a global commercialization strategy.

    Learn more: www.nano-qt.com

    Contact Information

    Dai Tsukada
    Head of Operations
    info@nano-qt.com

    .

    SOURCE: Nanofiber Quantum Technologies, Inc.

    Related Images

    NanoQT’s Proprietary Nanofiber-Cavity
    NanoQT’s Proprietary Nanofiber-Cavity

    View the original press release on ACCESS Newswire

  • Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK

    Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK

    The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population

    The facility marks a cornerstone of Moderna’s ten-year strategic partnership with the UK Government, designed to strengthen health resilience and drive economic growth

    CAMBRIDGE, MA / ACCESS Newswire / September 24, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK has officially opened. The MITC will now produce British-made mRNA respiratory vaccines for the UK public to support the National Health Service (NHS) seasonal vaccination programs. Beyond respiratory diseases, the MITC will also support research into the potential of mRNA science in areas such as cancer, rare diseases and immune disorders.

    “The opening of the Moderna Innovation and Technology Centre marks the first facility in the UK to manufacture an onshore supply of mRNA vaccines,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Our strategic partnership with the UK has already delivered more than 20 clinical trials across 110 sites nationwide, making Moderna the largest commercial sponsor of trials in the country. Together, we successfully delivered this vision from concept to operational readiness in under two years. This latest milestone underscores the UK’s commitment to improving health security, both against global health emergencies and ongoing seasonal respiratory threats.”

    The site can produce up to 100 million mRNA vaccine doses per year, with the capacity to increase to 250 million in the event of a pandemic. The Clinical R&D facility at the MITC also includes laboratories that will analyze samples from Moderna’s clinical trials globally.

    The MITC is part of a global network of advanced manufacturing hubs, alongside facilities in Australia and Canada, that collectively strengthen pandemic readiness by maximizing geographic coverage and minimizing response times.

    About Moderna

    Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

    Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna’s strategic partnership with the UK government; details of Moderna’s ongoing and planned R&D activities in the UK; the potential applications of Moderna’s mRNA platform; and the production capacity and timing for releases of vaccines to be produced at the MITC. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control, and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (SEC), and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

    Moderna Contacts

    Media:
    Chris Ridley
    Head of Global Media Relations
    +1 617-800-3651
    Chris.Ridley@modernatx.com

    Investors:
    Lavina Talukdar
    Senior Vice President & Head of Investor Relations
    +1 617-209-5834
    Lavina.Talukdar@modernatx.com

    SOURCE: Moderna, Inc.

    View the original press release on ACCESS Newswire

  • Kaye Allene Allen: Faith, Resilience, and Speaking to the Next Generation

    Kaye Allene Allen: Faith, Resilience, and Speaking to the Next Generation

    Beyond the Manuscript Evrima Chicago

    NAPERVILLE, IL / ACCESS Newswire / September 24, 2025 /

    Kaye Allene Allen: Faith, Resilience, and Speaking to the Next Generation

    Introduction: A Voice Born Out of Trial

    When an author writes after crisis, the words are never just words. They are survival, testimony, and offering. For Kaye Allene Allen, the manuscript What Does He Say to the Next Generation is not merely a book. It is the vineyard she never expected to plant, sown after a stroke reshaped her body, her ministry, and her sense of purpose.

    The Calling Behind the Pages

    Allen frames her story with candor. Before illness, she was a pastor, teacher, and women’s ministry leader. After illness, she felt stripped of assignment and identity until prayer, scripture, and memory recalled her to a new form of ministry: discipling the young.

    Where some might see a setback, Allen saw a summons. Her book, written as a series of structured lessons, is a way of pouring spiritual inheritance into a generation facing distraction, anxiety, and fractured cultural signals.

    Lessons as Blueprints for Character

    Each chapter in Allen’s book functions less as abstract theology and more as apprenticeship in living.

    • Obedience is framed not as blind compliance but as building life on a rock-solid foundation.

    • Prayer is not ritual recitation but light in the darkness of overwhelm.

    • The Fruits of the Spirit become virtues tested not in theory but in cafeterias, friendships, and late-night decisions.

    • Forgiveness, trust, patience, and truth are presented in language young readers can practice, memorize, and carry into their daily battles.

    Allen’s pedagogy is deliberate: memorize scripture, apply it, reflect on it, pray it, and write about it. Each lesson is scaffolded with reflection questions and journal space, anchoring learning not in passive reading but in lived practice.

    The Vineyard Metaphor

    When Allen speaks of her “vineyard,” she is invoking Jeremiah’s imagery of rebuilding and fruit-bearing. Her vineyard is not soil and vine, but classroom and heart. By focusing on the next generation, she aligns herself with the ancient mandate of Titus 2 – that older women and men disciple the young, passing wisdom not through abstract sermons but through lived mentorship.

    Why This Work Matters

    In a moment when American youth culture is shaped by fragmented digital voices, Allen’s text stands as a counter-narrative. It is a manual of rootedness. More than that, it represents a transfer of spiritual capital: the hard-won lessons of an elder poured into the fragile vessels of the young.

    Her book reminds us that manuscripts are not just records. They are inheritances. And in this case, inheritance is not wealth or property, but instruction, discipline, and encouragement.

    Beyond the Manuscript

    What makes Allen a fit for our Beyond the Manuscript series is that her book is not simply literature. It is lived theology. Born of physical limitation, it teaches spiritual resilience. Written for children and youth, it models intergenerational responsibility.

    In Allen’s case, the manuscript itself is only the beginning. Each verse memorized, each prayer written in a journal, each child mentored becomes a continuation of the text. Her vineyard grows not in pages but in people.

    Conclusion: From Stroke to Seed

    If every manuscript carries both a story and a purpose, What Does He Say to the Next Generation carries Allen’s renewed purpose after loss. It is her answer to the question, “Lord, what now?”

    For Evrima Chicago, highlighting Allen’s journey is to remind readers of what Beyond the Manuscript stands for: that the most powerful manuscripts are not only read but lived. And that sometimes, the fruit of a book is not found on shelves, but in lives transformed.

    Disclaimer

    • This is a critical, opinion-based cultural analysis authored by the Editorial Team and reflects their personal editorial perspective.

    • The views expressed do not represent the institutional stance of Evrima Chicago.

    • The article draws from open-source information, legal filings, published interviews, and public commentary.

    • All allegations referenced remain under investigation or unproven in a court of law.

    • No conclusion of criminal liability or civil guilt is implied.

    • Any parallels made to public figures are interpretive in nature and intended to examine systemic patterns of influence, celebrity, and accountability in American culture.

    • Where relevant, satirical, rhetorical, and speculative language is used to explore public narratives and their societal impact.

    • Readers are strongly encouraged to engage critically and examine primary sources where possible.

    • This piece is protected under the First Amendment of the U.S. Constitution and published under recognized standards of opinion journalism.

    • Editorial inputs contact: waasay@evrimachicago.com

    • Evrima Chicago remains committed to a clear distinction between fact-based reporting and individual editorial perspective.

    PR & Media Contact
    Dan Wasserman
    pr@evrimachicago.com

    SOURCE: Kaye Allene Allen

    View the original press release on ACCESS Newswire

  • QumulusAI Appoints Former Applied Digital CTO Michael Maniscalco as CEO to Lead Growth in AI Infrastructure Market

    QumulusAI Appoints Former Applied Digital CTO Michael Maniscalco as CEO to Lead Growth in AI Infrastructure Market

    ATLANTA, GA / ACCESS Newswire / September 25, 2025 / QumulusAI, a provider of GPU-powered cloud infrastructure for artificial intelligence, today announced the appointment of Michael Maniscalco as Chief Executive Officer to propel the company through a rapid growth phase.

    Maniscalco, formerly CTO of Applied Digital, brings deep expertise in scaling high-performance computing platforms – under his leadership at Applied Digital, his team deployed 6,000 state-of-the-art GPUs in 12 months. At QumulusAI, he will drive expansion of the company’s differentiated approach of owning the full stack – from energy and data centers to GPU-accelerated cloud services – delivering cost-efficient, enterprise-grade AI infrastructure with the speed to move fast and the scale to grow with customers.

    The company also announced two additional executive appointments: Ryan DiRocco as Chief Technology Officer and Stephen Hunton as Chief Marketing Officer. DiRocco, previously CTO at Performive LLC, a leading VMware-focused managed multicloud provider. In this role, he will oversee QumulusAI’s technical strategy, ensuring products are secure, high-performing, and aligned with customer needs, while guiding clients’ smooth, cost-effective adoption of AI.

    Hunton, who most recently served as Head of Global Social and Content Experience at IBM, adds global marketing expertise from Google, YouTube and Chevrolet. In this role, Hunton will focus on establishing the brand as the category leader in AI infrastructure – driving market visibility, accelerating enterprise adoption, and building the momentum that will fuel long-term value for customers and partners/investors.

    The strengthened leadership team will focus on expanding market presence, accelerating product innovation, and building strategic partnerships as QumulusAI advances its mission to make enterprise-grade AI supercomputing more accessible.

    “These appointments mark a pivotal inflection point for QumulusAI,” said Steve Gertz, Chairman of the Board. “AI adoption is accelerating across every industry, and the ability to deliver scalable, cost-efficient infrastructure has become a critical enabler. Michael, Ryan, and Stephen bring proven expertise in building technology platforms, scaling infrastructure, and creating global brands. This team has the vision and execution experience needed to establish QumulusAI as a premier AI infrastructure provider.”

    “The demand for scalable AI infrastructure is one of the fastest-growing markets in tech,” said Steven Dickens, CEO & Principal Analyst at HyperFrame Research. “QumulusAI’s model of controlling the full stack positions it to deliver performance and economics that many enterprises simply can’t get from hyperscalers. Adding Michael Maniscalco as CEO is a strong signal the company is ready to scale.”

    About QumulusAI

    QumulusAI is a vertically integrated AI infrastructure company building the most resilient distributed AI cloud, by innovating around power, data center and GPU-based cloud services-the company delivers access at hyperspeed to high-performance computing with enhanced cost control, reliability, and flexibility. Machine learning teams, AI startups, research institutions, and growing enterprises can now scale their AI training and inference workloads quickly and cost effectively.

    For more information, visit https://www.qumulusai.com

    Press: media@qumulusai.com

    Investors: investors@qumulusai.com

    Follow QumulusAI on social media: https://www.linkedin.com/company/qumulusai

    SOURCE: QumulusAI

    View the original press release on ACCESS Newswire

  • Higher-Education Institutions Turn to Mentavi Health to Reduce Diagnostic Delays and Support Student Success

    Higher-Education Institutions Turn to Mentavi Health to Reduce Diagnostic Delays and Support Student Success

    Mentavi’s clinically validated, asynchronous ADHD assessment – recently published in the Journal of Clinical Psychiatry – shortens wait times from months to days and empowers students to access timely support.

    GRAND RAPIDS, MICHIGAN / ACCESS Newswire / September 25, 2025 / As the back-to-school season begins, the strain of transition extends beyond students to parents, professors, and staff. Limited campus resources often mean long waits for ADHD, anxiety, or depression evaluations, delaying care and harming academic performance.

    Mentavi Health‘s clinically validated, asynchronous Diagnostic Evaluation – the first online assessment for adult ADHD validated against the current standard of care and now peer-reviewed and published in the Journal of Clinical Psychiatry – reduces waits from weeks to days, giving students timely answers when they matter most.

    “Early identification and treatment of ADHD and related mental health conditions is crucial for improved clinical outcomes,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. “Timely diagnosis allows students to access the right accommodations and support to stay on track academically and personally.”

    Mentavi now serves more than a dozen higher-education institutions nationwide and has completed over 20,000 student evaluations, demonstrating both the scalability of its services and the value institutions place on timely, validated mental health support. Publication in the Journal of Clinical Psychiatry, one of the field’s leading peer-reviewed journals, further underscores Mentavi’s commitment to scientific rigor and expanding evidence-based access to care.

    “For many of our students, the greatest challenge isn’t the classroom itself but the invisible barriers that prevent them from accessing the accommodations they are entitled to under federal law,” said Jana Garnett, DSPS Coordinator/Director at Santa Barbara City College. “By making professional diagnoses accessible and affordable, Mentavi gives our students a pathway to the support they need to persist and succeed in college.”

    Efficient and affordable support

    Students can complete the Diagnostic Evaluation independently in one to two hours. Each evaluation is reviewed by a licensed, doctorate-level clinician – not automated AI – with results delivered within five days. Students may then share their results with the appropriate offices at their college or university to discuss accommodations or treatment options when warranted. 

    Alternatively, in over 40 states, students can choose to meet with a Mentavi clinician to explore therapy, medical treatment, or coaching. This flexibility allows institutions to either keep students within their own health systems or to expand support through Mentavi’s nationwide network. At $189 per evaluation, Mentavi’s service is also far more affordable than traditional in-clinic assessments.

    Improved student outcomes and institutional reputation

    Early and accurate diagnosis empowers students to understand their challenges, access the right support, and adopt strategies that improve performance, strengthen retention, and build adaptability for life after graduation. For institutions, providing timely answers demonstrates a commitment to student well-being and reduces the risk of students falling behind.

    “With national discussions underway about stimulant and non-stimulant treatments, and with increasing state-level scrutiny of AI in healthcare, Mentavi stands out by combining validated assessments with a human-centered model: every evaluation is reviewed by a licensed clinician, ensuring accuracy and accountability,” said Keith Brophy, CEO of Mentavi Health.

    “Our mission has always been to make clinically validated mental health care accessible and affordable. As the new school year begins, higher-education institutions seek proven ways to support their students while managing limited resources. By partnering with Mentavi, colleges and universities can offer timely, evidence-based diagnosis and care as appropriate that reduces the stress families, faculty, and staff feel during this critical transition period.”

    For more information, visit Mentavi Health or ADHD Online. The Mentavi Health Diagnostic Evaluation is clinically validated for the diagnosis of ADHD in adults. Study results were published in the Journal of Clinical Psychiatry on September 8, 2025 (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

    About Mentavi Health and ADHD Online

    Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Mental Health Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

    Media contact:

    Tim Cox, ZingPR for Mentavi Health
    tim@zingpr.com

    .

    SOURCE: Mentavi Health

    Related Images

    View the original press release on ACCESS Newswire

  • Fetcherr Raises $42M in Series C Funding Led by Salesforce Ventures

    Fetcherr Raises $42M in Series C Funding Led by Salesforce Ventures

    Existing investors Battery Ventures, Left Lane Capital, and M-Fund also joined to fuel Fetcherr’s global growth and cross-industry expansion

    TEL AVIV, IL / ACCESS Newswire / September 25, 2025 / Fetcherr, a pioneer in generative AI for strategic decision-making, today announced the closing of a $42 million Series C funding round led by Salesforce Ventures. Previous investors Battery Ventures, Left Lane Capital and M-Fund also participated, signaling continued confidence in Fetcherr’s category-defining performance and vision to transform the travel sector and beyond.

    “Fetcherr has established itself as an essential revenue driver and a turnkey technology partner for some of the world’s leading airlines,” said Roy Cohen, Co-Founder and CEO of Fetcherr. “We’re thrilled to welcome Salesforce Ventures as a growth partner. With the support of our investors, we’re set to expand beyond aviation and into other legacy sectors where real-time, data-driven decision-making is long overdue.”

    Fetcherr is the industry’s first AI-native market engine designed to understand complex market dynamics, forecast demand, and generate real-time pricing, inventory and resource management decisions based on predicted market behavior across all variables. Fetcherr’s proprietary system, anchored by its Large Market Model (LMM), has already delivered significant impact for airline partners by enabling granular, predictive pricing that responds instantly to market demand.

    “Industries across the board are undergoing seismic shifts with AI – the need for intelligent, automated systems isn’t optional, it’s more critical than ever,” said Nowi Kallen, Managing Director at Salesforce Ventures. “Fetcherr’s AI platform is expanding the possibilities of generative AI for enterprises still dependent on outdated logic and forecasting. We look forward to supporting their next chapter of global growth and expansion into new domains.”

    The new capital will accelerate Fetcherr’s ongoing growth trajectory as it enters new international markets and industries, earning its place among next-generation technology leaders reshaping enterprise infrastructure. Airlines already using Fetcherr’s technology can make automated, insight-backed micro and macro decisions, powered by multi-dimensional views of the global market and economy. A growing partner network, including Delta Air Lines, Virgin Atlantic, WestJet, Viva Aerobus and Azul, underscores Fetcherr’s rapid rise and potential across industries.

    About Fetcherr

    Fetcherr is a generative AI company that has developed a unique, AI-driven market engine. Its proprietary Large Market Model (LMM) revolutionizes business decision-making by generating real-time market insights from diverse data sources and seamlessly executing critical business decisions through its advanced AI architecture. Built on deep learning principles, Fetcherr’s transparent approach offers explainable insights for predictive pricing, inventory management, and resource optimization. This secure, cloud-based, and seamless solution integrates easily with existing infrastructure, reducing IT overhead and enabling swift adoption. Fetcherr disrupts traditional, rule-based revenue systems, leveraging deep learning to position businesses to become next-generation, AI-driven organizations. For more information, please visit www.fetcherr.io.

    Media Contact
    fetcherr@5wpr.com

    SOURCE: Fetcherr

    View the original press release on ACCESS Newswire

  • American Meltblown & Filtration, Inc. Rebrands as American Filter Manufacturing Inc.

    American Meltblown & Filtration, Inc. Rebrands as American Filter Manufacturing Inc.

    AFM rebrand highlights private-label expertise, expanded global reach, and complete solutions for water, food & beverage, pharmaceutical, and industrial markets.

    RENSSELAER, IN / ACCESS Newswire / September 25, 2025 / American Meltblown & Filtration, Inc. (AMBF) announced today it will officially change its name to American Filter Manufacturing Inc. (AFM), effective October 1, 2025. The new name reflects the company’s evolution from a meltblown cartridge specialist into a large-scale filtration manufacturer with one of the most complete product lines in the industry.

    American Filter Manufacturing
    American Filter Manufacturing
    American Filter Manufacturing – AFM
    Liquid Filter Housings – LFH

    Founded in 2011, AFM has built its reputation on “Filtration Without Compromise”, delivering solutions that protect water, processes, and people worldwide. Operating from a 148,000 sq. ft. U.S. facility with over 100 employees, AFM manufactures meltblown, pleated, string-wound, high-flow, carbon, and membrane cartridges.

    As part of AFM’s commitment to having the most complete product line, its sister company, Liquid Filter Housings, Inc. (LFH) will merge into AFM. Continuing to operate as Liquid Filter Housings, it supplies the industry’s most durable liquid filtration housings solutions. Together, AFM and LFH deliver a complete filtration solution-cartridges, medias, and housings engineered to work seamlessly as one system.

    AFM specializes in private-label manufacturing, controlling every step of production – from raw plastic pellets to finished products. This vertical integration ensures consistent quality, reliability, and flexibility to meet diverse customer needs. Products are shipped across North America, Europe, the Middle East, Latin America, and Australia, serving industries such as water treatment, food & beverage, pharmaceuticals, and industrial/chemical processing.

    “As our capabilities have expanded, the name American Filter Manufacturing reflects both who we are today and where we’re headed,” said Fred Geyer, President. “Together with LFH, we’re proud to deliver full-system filtration solutions while investing in new technologies that address tomorrow’s challenges.”

    The company’s leadership and ownership remain unchanged. Customers will begin seeing the new AFM name and branding in October 2025.

    Media Contact:
    Adam Albrecht
    Vice President
    American Filter Manufacturing Inc.
    adam.albrecht@afm.us
    www.afm.us

    .

    SOURCE: American Filter Manufacturing

    View the original press release on ACCESS Newswire

  • BitBridge Capital Strategies Announces Multi-Year Sponsorship Partnership with UCF Athletics

    BitBridge Capital Strategies Announces Multi-Year Sponsorship Partnership with UCF Athletics

    BOCA RATON, FL / ACCESS Newswire / September 25, 2025 / BitBridge Capital Strategies Inc. (OTC:BTTL) (the “BitBridge”), a pioneering American Bitcoin treasury company dedicated to bridging traditional finance with the power of Bitcoin, today announced a multi-year sponsorship agreement with Playfly Sports Properties, the exclusive multimedia rights holder for University of Central Florida (UCF) Athletics. This partnership positions BitBridge as a “Proud Partner of UCF Athletics/Knights,” enhancing visibility and engagement with one of the nation’s most dynamic college sports programs.

    The agreement provides BitBridge with a range of high-impact sponsorship opportunities focused on UCF’s football program and broader athletics ecosystem. The Bitcoin Is Life slogan and planned Bitcoin Respect Loan product will be the prominent focus of the campaign. Key elements include:

    • Signage and Exposure at Home Football Games: Prominent placement on the Field Level Tunnel, Fascia, and South End Zone displays at each regular-season home game at Acrisure Bounce House; and inclusion in Fan Connect Banner ad rotations with a 30-second commercial spot on select stadium TVs.

    • Activation Opportunities: On-site engagement during pre-game festivities in every regular-season home football game, allowing BitBridge to connect directly with fans.

    • Digital Presence: Logo placement on the UCF Athletics Corporate Partner page.

    This collaboration supports BitBridge’s mission to integrate innovative financial strategies into high-visibility platforms, reaching Knight Nation’s passionate fan base while aligning with UCF’s commitment to excellence in athletics.

    “We are thrilled to partner with UCF Athletics, a program that embodies innovation, resilience, and forward-thinking – just like BitBridge,” said Paul Jaber, Executive CEO of BitBridge Capital Strategies. “This sponsorship allows us to engage with a vibrant community that understands both bitcoin and the public markets. We’re excited to charge on with the Knights as we showcase how Bitcoin treasury strategies can empower the future of finance.”

    “BitBridge’s forward-looking approach to finance makes them an ideal partner for UCF Athletics,” added Garrett Altier, General Manager of Playfly Sports Properties at UCF. “This agreement not only strengthens our sponsorship portfolio but also brings new energy to our game-day experiences and digital platforms. We are proud to welcome BitBridge to the Knight Nation family.”

    About BitBridge Capital Strategies Inc.
    BitBridge Capital Strategies is an American Bitcoin treasury company that empowers individuals and institutions to unlock liquidity and protect generational wealth through strategic Bitcoin investments and innovative lending solutions. By allocating its balance sheet primarily to Bitcoin, BitBridge preserves purchasing power and capitalizes on long-term appreciation, while its consumer-facing initiatives promote Bitcoin education and adoption. With a focus on innovative financial strategies, including disruptive Bitcoin lending, and its bold Bitcoin Is Life branding campaign, BitBridge aims to deliver. Headquartered in Boca Raton, Florida, the company expects to begin trading in the late third quarter and will provide market updates as its listing process progresses. Follow us on https://x.com/BitBridgebtc and visit https://bitbridgebtc.com/ or contact investor relations at ir@bitbridgebtc.com.

    About UCF Athletics
    UCF is a proud member of the Big 12 Conference. Our mission is to positively transform the lives of our students academically, athletically, and personally through a nationally competitive intercollegiate athletics program that enhances the reputation and visibility of the University. We strive to be Florida’s preeminent athletic program representing UCF and our community with distinction on the national stage as “Orlando’s Hometown Team”. To learn more about UCF and Athletics, please visit our websites at www.ucf.edu and www.ucfknights.com.

    About Playfly Sports
    Playfly Sports is the leading revenue maximizer in the sports industry. Our consultative, data-driven approach to reach, engage, monetize, and measure fandom powers partnerships with premier athletic departments and conferences across the U.S.

    Forward-Looking Statements:
    This press release contains forward-looking statements based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to a variety of factors. These statements are not guarantees of future performance, and BitBridge disclaims any obligation to update them, except as required by law.

    Media Contact:
    Leah Messina
    Director of Communications for BitBridge
    Email: leah@sinuatemedia.com
    Phone: 917-843-8164

    SOURCE: BitBridge Capital Strategies Inc.

    View the original press release on ACCESS Newswire